Duy-Tai Nguyen
About Duy-Tai Nguyen
Duy-Tai Nguyen is a Software Engineering Manager at Segmed, involved in various projects including FDA approvals, dataset curation for pharmaceutical clients, and the development of the Insight data platform.
Software Engineering Manager at Segmed
Duy-Tai Nguyen holds the position of Software Engineering Manager at Segmed. Since the company's inception, he has played a critical role in its growth and development. In his capacity as a manager, he leads a team focused on cohort-building and addressing data requests. His expertise extends to curating datasets for customers, particularly within the pharmaceutical sector, enabling them to leverage robust and accurate data.
Collaboration with Clinical Scientists
Duy-Tai Nguyen works closely with clinical scientists at Segmed. Together, they focus on cohort-building and fulfilling specific data requests. This collaboration is key to ensuring the quality and relevance of the data provided to customers. His work strengthens the interaction between software engineering and clinical science, facilitating a smooth and efficient data curation process.
Projects in FDA Approvals and CE Marks
In his tenure at Segmed, Duy-Tai Nguyen has been involved in critical projects preparing for FDA approvals and CE marks. These projects are essential for ensuring that the products and services offered by Segmed meet strict regulatory standards. His contributions in this area reflect his commitment to maintaining high-quality and compliant solutions within the medical data industry.
Development and Maintenance of Segmed Insight
Duy-Tai Nguyen contributes significantly to the development and maintenance of Segmed's proprietary data platform, Insight. This platform is central to the company's operations, providing a reliable and efficient system for data management and analytics. His role ensures the platform remains robust, secure, and capable of handling diverse data sets from various sectors, including pharmaceuticals.
Participation in SCOPE 2024 Conference
As part of Segmed's initiative to advance clinical trials and research, Duy-Tai Nguyen participated in the SCOPE 2024 Conference. This involvement highlights his active engagement in industry events and his dedication to staying at the forefront of clinical research advancements. His participation underscores Segmed's commitment to integrating Real World Data with Randomized Controlled Trials and enhancing the quality of clinical research data.